119 related articles for article (PubMed ID: 37333140)
41. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis.
Li D; Xia L; Huang P; Wang Z; Guo Q; Huang C; Leng W; Qin S
Cell Death Discov; 2023 Jan; 9(1):17. PubMed ID: 36681667
[TBL] [Abstract][Full Text] [Related]
42. Modulated interaction of the ERM protein, moesin, with CD93.
Zhang M; Bohlson SS; Dy M; Tenner AJ
Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698
[TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor binding protein 7 exhibits tumor suppressive and vessel stabilization properties in U87MG and T98G glioblastoma cell lines.
Pen A; Durocher Y; Slinn J; Rukhlova M; Charlebois C; Stanimirovic DB; Moreno MJ
Cancer Biol Ther; 2011 Oct; 12(7):634-46. PubMed ID: 21795858
[TBL] [Abstract][Full Text] [Related]
44. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
[TBL] [Abstract][Full Text] [Related]
45. Radioimmunoimaging of
Liu W; Zhang C; Cao H; Shi D; Zhao S; Liang T; Hou G
Oncol Lett; 2019 Dec; 18(6):6413-6422. PubMed ID: 31819775
[TBL] [Abstract][Full Text] [Related]
46. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
Greenlee-Wacker MC; Briseño C; Galvan M; Moriel G; Velázquez P; Bohlson SS
J Immunol; 2011 Sep; 187(6):3353-61. PubMed ID: 21849679
[TBL] [Abstract][Full Text] [Related]
47. Association of insulin-like growth factor binding protein-7 promoter methylation with esophageal cancer in peripheral blood.
Kaya Z; Almalı N; Sahin ES; Duran S; Görgisen G; Ates C
Mol Biol Rep; 2022 May; 49(5):3423-3431. PubMed ID: 35076852
[TBL] [Abstract][Full Text] [Related]
48. Cell surface expression of C1qRP/CD93 is stabilized by O-glycosylation.
Park M; Tenner AJ
J Cell Physiol; 2003 Sep; 196(3):512-22. PubMed ID: 12891708
[TBL] [Abstract][Full Text] [Related]
49. First Trimester CD93 as a Novel Marker of Preeclampsia and Its Complications: A Pilot Study.
Piani F; Tossetta G; Fantone S; Agostinis C; Di Simone N; Mandalà M; Bulla R; Marzioni D; Borghi C
High Blood Press Cardiovasc Prev; 2023 Nov; 30(6):591-594. PubMed ID: 38010536
[TBL] [Abstract][Full Text] [Related]
50. Crosstalk between CD93, C1q and GIPC in the Regulation of Pneumococcal Meningitis Inflammation.
Qiao N; Zhang J; Zhang Y; Liu X
Ann Clin Lab Sci; 2022 Jul; 52(4):634-641. PubMed ID: 36197773
[TBL] [Abstract][Full Text] [Related]
51. CD93 is Selectively Expressed on Human Myeloma Cells but Not on B Lymphocytes.
Fakhari S; Bashiri H; Ghaderi B; Tari K; Jalili A
Iran J Immunol; 2019 Jun; 16(2):142-150. PubMed ID: 31182688
[TBL] [Abstract][Full Text] [Related]
52. IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway.
Li X; Zhang J; Wu Y; Ma C; Wei D; Pan L; Cai L
Oncol Lett; 2022 Aug; 24(2):251. PubMed ID: 35761941
[TBL] [Abstract][Full Text] [Related]
53.
Lee WC; Russell B; Sobota RM; Ghaffar K; Howland SW; Wong ZX; Maier AG; Dorin-Semblat D; Biswas S; Gamain B; Lau YL; Malleret B; Chu C; Nosten F; Renia L
Elife; 2020 Feb; 9():. PubMed ID: 32066522
[TBL] [Abstract][Full Text] [Related]
54. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.
Chevrier S; Genton C; Kallies A; Karnowski A; Otten LA; Malissen B; Malissen M; Botto M; Corcoran LM; Nutt SL; Acha-Orbea H
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3895-900. PubMed ID: 19228948
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effect of insulin-like growth factor-binding protein-7 (IGFBP7) on in vitro angiogenesis of vascular endothelial cells in the rat corpus luteum.
Tamura K; Yoshie M; Hashimoto K; Tachikawa E
J Reprod Dev; 2014; 60(6):447-53. PubMed ID: 25212428
[TBL] [Abstract][Full Text] [Related]
56. Detection and characterization of soluble CD93 released during inflammation.
Greenlee MC; Sullivan SA; Bohlson SS
Inflamm Res; 2009 Dec; 58(12):909-19. PubMed ID: 19603257
[TBL] [Abstract][Full Text] [Related]
57. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
[TBL] [Abstract][Full Text] [Related]
58. CD93 as a Potential Target in Neovascular Age-Related Macular Degeneration.
Tosi GM; Caldi E; Parolini B; Toti P; Neri G; Nardi F; Traversi C; Cevenini G; Marigliani D; Nuti E; Bacci T; Galvagni F; Orlandini M
J Cell Physiol; 2017 Jul; 232(7):1767-1773. PubMed ID: 27859225
[TBL] [Abstract][Full Text] [Related]
59. An Integrated Transcriptome Analysis Reveals IGFBP7 Upregulation in Vasculature in Traumatic Brain Injury.
Wang J; Deng X; Xie Y; Tang J; Zhou Z; Yang F; He Q; Cao Q; Zhang L; He L
Front Genet; 2020; 11():599834. PubMed ID: 33505428
[TBL] [Abstract][Full Text] [Related]
60. Deficiency of CD93 exacerbates inflammation-induced activation and migration of BV2 microglia by regulating the TAK1/NF-κB pathway.
Hong X; Xia M; Zhang Q; Zhao T; Zhang Y; Qian Z; Bao J; Li H
Neurosci Lett; 2022 Nov; 791():136914. PubMed ID: 36270452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
